Tag - glaxosmithkline

 
Menu
Search
 
May 09, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

GLAXOSMITHKLINE

Japan Times
JAPAN / Science & Health
Sep 27, 2021
Japan approves second drug for mildly ill COVID-19 patients
Sotrovimab was given the green light three weeks after GlaxoSmithKline's Japan unit submitted its application for the antibody treatment to the health ministry.
Japan Times
WORLD / Science & Health
Oct 9, 2019
GSK recalls popular heartburn drug Zantac globally amid cancer scare
GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a "precaution," days after the U.S. Food and Drug Administration found "unacceptable" levels of probable cancer-causing impurity in the drug.
CULTURE / TV & Streaming / CHANNEL SURF
Feb 6, 2015
Sumo tournament; "The Eternal Zero"; CM of the week: GlaxoSmithKline
If you like sumo but think the two-week basho schedule is too much, then check out "Nihon Ozumo Tournament Dai-Sanjukyu-kai Taikai" ("39th Japan Grand Sumo Tournament"; Fuji TV, Sun., 4:05 p.m.), which compresses the whole thing into a 90-minute event.
Japan Times
BUSINESS / Companies
Sep 20, 2014
China fines drugmaker GSK record $489 million for bribing doctors to use its drugs
Adam Jourdan and Ben Hirschler
WORLD / Science & Health
Aug 28, 2014
Glaxo's Ebola vaccine may begin safety tests in humans next week
U.S. scientists will begin enrolling patients as soon as next week in clinical safety trials of GlaxoSmithKline PLC's experimental Ebola vaccine as the death toll from the disease rises in West Africa.
WORLD / Science & Health
Aug 26, 2014
Canada's Immunovaccine says test of Ebola vaccine appears promising
Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc.'s technology, the tiny Canadian company said on Monday, and the announcement sent its stock soaring.
Japan Times
WORLD / Science & Health
Aug 21, 2014
Experimental Ebola drugs needed for 'up to 30,000 people'
Up to 30,000 people could have used experimental treatments or vaccines so far in the world's worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday.
Japan Times
WORLD / Science & Health
Aug 13, 2014
WHO hopes for more Ebola drug doses, vaccine progress by end of year
World Health Organization experts fighting the world's worst outbreak of Ebola hope for improved supplies of experimental treatments and progress with a vaccine by the end of the year.
BUSINESS
Jul 25, 2014
GSK corruption allegations spread to Syria
GlaxoSmithKline faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's email reviewed by Reuters.
Japan Times
BUSINESS / Companies
Dec 4, 2013
Takeda breaks tradition with outsider at helm
Takeda Pharmaceutical Co., the more than 230-year-old drugmaker, is starting to make a practice of breaking with tradition.
Tokuryū, a new crime menace in Japan, emerges from the shadows
The National Police Agency coined the term "tokuryū" to classify individuals involved in dark part time jobs and quasi-gangsters, using the words "tokumei" (anonymous) and "ryūdo" (fluid) to reflect their characteristics.
Thanks, tourists. Views of Mount Fuji are now blocked.
Tourists pose in front of a convenience store with Mount Fuji on Friday in the town of Fujikawaguchiko, Yamanashi Prefecture. Local residents are upset over littering, overcrowding and the inconvenience caused by the visitors.
Is Modi’s party heading for a stunning election loss?
Indian Prime Minister Narendra Modi's campaign tactics have escalated, including anti-Muslim rhetoric and fearmongering, reflecting his ruling party's desperation.
Two more arrested over brutal murder of couple in Tochigi
A vehicle carrying Seiha Sekine, the 32-year-old common-law husband of the deceased Tokyo couple's first daughter, leaves a police station in Tokyo's Shinagawa Ward on Tuesday.
After blockbuster boxing victory, what next for ‘Monster’ Inoue?
Naoya Inoue celebrates his victory over Luis Nery in their IBF-WBA-WBC-WBO super bantamweight title boxing match at Tokyo Dome on Monday.
Unlike 10 years ago, Japan's new security bill sparks little debate
The Lower House starts discussing a security clearance bill on April 19 in Tokyo.
After blockbuster boxing victory, what next for ‘Monster’ Inoue?
Naoya Inoue celebrates his victory over Luis Nery in their IBF-WBA-WBC-WBO super bantamweight title boxing match at Tokyo Dome on Monday.
Xi bristles as Macron and von der Leyen urge China to do more on Ukraine
French President Emmanuel Macron, Chinese leader Xi Jinping and European Commission chief Ursula von der Leyen walk after their meeting in Paris on Monday.
How a Japanese scientist is turning the climate crisis into music
A screencap of a performance of Hiroto Nagai's “String Quartet No. 1 ‘Polar Energy Budget’” by the PRT Quartet
Japan’s tween skateboarders get head start on preparations for 2028 Olympics
Ibuki Matsumoto competes at an event in Osaka on April 21.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Rows of irises resemble a rice field at the Peter Walker-designed Toyota Municipal Museum of Art.
The 'outsiders' creating some of Japan's greenest spaces
By Stephen Mansfield

SUSTAINABLE JAPAN

Cultural properties:A Fujiya Hotel insider’s view
Cultural properties:A Fujiya Hotel insider’s view

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER